Literature DB >> 3951568

An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes.

K G Charlton, R A Bond, D E Clarke.   

Abstract

The present study has identified a receptor for 5-hydroxytryptamine (5-HT) which functions to inhibit the stimulus-induced release of [3H] noradrenaline following sympathetic periarterial nerve stimulation to the isolated perfused rat kidney. In addition to 5-HT (IC30 = 4.5 X 10(-8) mol/l), both 5-carboxamidotryptamine (IC30 = 8 X 10(-9) mol/l) and 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl) indole (RU-24969, IC30 = 2.5 X 10(-7) mol/l) acted as agonists whereas 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) was inactive. The inhibitory effect of 5-HT on the electrically-evoked release of tritium was antagonized in a concentration-dependent manner by methiothepin (IC50 = 4 X 10(-9) mol/l), metergoline (IC50 = 4 X 10(-8) mol/l) and methysergide (IC50 = 1.3 X 10(-7) mol/l) but not by cyproheptadine, ketanserin, mesulergine, (-)-propranolol, (+/-)-pindolol, (+/-)-cyanopindolol, metoclopramide or phentolamine. It is concluded that the receptor to 5-HT conforms to general criteria defining 5-HT1-like receptors but at the present time the receptor site cannot be fitted to the designated 5-HT1A, 5-HT1B or 5-HT1C subtypes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951568     DOI: 10.1007/bf00633190

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  46 in total

1.  The basic requirements for the function of the isolated cell free perfused rat kidney.

Authors:  H J Schurek; J P Brecht; H Lohfert; K Hierholzer
Journal:  Pflugers Arch       Date:  1975       Impact factor: 3.657

2.  Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors.

Authors:  P R Saxena; E J Mylecharane; J Heiligers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

Review 3.  Peripheral 5-hydroxytryptamine receptors and their classification.

Authors:  P P Humphrey
Journal:  Neuropharmacology       Date:  1984-12       Impact factor: 5.250

4.  Hypotensive activity of serotonin receptor agonists in rats is related to their affinity for 5-HT1 receptors.

Authors:  H O Kalkman; H W Boddeke; H N Doods; P B Timmermans; P A Van Zwieten
Journal:  Eur J Pharmacol       Date:  1983-07-15       Impact factor: 4.432

Review 5.  Prejunctional effects of 5-hydroxytryptamine on noradrenergic nerves in the cardiovascular system.

Authors:  P P Humphrey; W Feniuk; A D Watts
Journal:  Fed Proc       Date:  1983-02

Review 6.  Serotonin receptor binding sites: is there pharmacological and clinical significance?

Authors:  J Leysen
Journal:  Med Biol       Date:  1983-06

7.  Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist.

Authors:  K Gradin; A Pettersson; S Hjorth; T Hedner; L E Arvidsson; B Persson
Journal:  J Pharm Pharmacol       Date:  1985-04       Impact factor: 3.765

8.  Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol.

Authors:  D N Middlemiss
Journal:  Eur J Pharmacol       Date:  1984-06-01       Impact factor: 4.432

9.  Modification of the vasomotor actions of methysergide in the femoral arterial bed of the anaesthetized dog by changes in sympathetic nerve activity.

Authors:  W Feniuk; P P Humphrey; A D Watts
Journal:  J Auton Pharmacol       Date:  1981-03

10.  Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.

Authors:  J C Doxey; A G Roach; C F Smith
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

View more
  20 in total

1.  The effects of ageing on prejunctional 5-hydroxytryptamine receptors in the rat vas deferens.

Authors:  M Borton; J R Docherty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Investigations of cardiovascular 5-hydroxytryptamine receptor subtypes in the rat.

Authors:  J R Docherty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

3.  Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.

Authors:  G Hewson; G E Leighton; R G Hill; J Hughes
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

4.  Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery.

Authors:  S Tadipatri; D van Heuven-Nolsen; W Feniuk; P R Saxena
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

Review 5.  [Modulation of renal transmitter release by presynaptic receptors].

Authors:  L C Rump; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1989-09-01

6.  Phentolamine blocks presynaptic serotonin autoreceptors in rabbit and rat brain cortex.

Authors:  N Limberger; M R Fischer; T Wichmann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

7.  Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of "5-hydroxytryptamine1-like" receptors.

Authors:  P R Saxena; D J Duncker; A H Bom; J Heiligers; P D Verdouw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

8.  Evidence for a noradrenergic innervation to alpha 1A-adrenoceptors in rat kidney.

Authors:  D R Blue; R L Vimont; D E Clarke
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

9.  Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava.

Authors:  G J Molderings; K Fink; E Schlicker; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

10.  Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion.

Authors:  S J Ireland; C C Jordan
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.